GILD

Gilead Sciences, Inc. News Headlines

$105.47
*  
0.49
0.46%
Get GILD Alerts
*Delayed - data as of Sep. 22, 2014  -  Find a broker to begin trading GILD now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Glaxo Fined Roughly $484M in China Bribery Probe - Analyst Blog
9/22/2014 5:45:00 PM - Zacks.com

Isis Pharmaceuticals Up on $4M Milestone Payment - Analyst Blog
9/22/2014 5:40:00 PM - Zacks.com

Gilead's (GILD) Zydelig Gets EU Clearance for Blood Cancer - Analyst Blog
9/22/2014 5:20:00 PM - Zacks.com

Flexion Continues to Fall Post Clinical Hold on FX006 - Analyst Blog
9/22/2014 3:59:00 PM - Zacks.com

Surprising Silver Lining for Gilead Sciences, inc. Stock
9/22/2014 3:37:02 PM - Motley Fool

Gilead Sciences: A Preview of Important HIV Drug Study Results
9/22/2014 12:44:00 PM - TheStreet

Dynavax (DVAX) Jumps: Stock Moves 6.7% Higher - Tale of the Tape
9/22/2014 9:46:00 AM - Zacks.com

Cytori Therapeutics (CYTX) Jumps: Stock Rises 6.4% - Tale of the Tape
9/22/2014 9:39:00 AM - Zacks.com

Vertex Pharmaceuticals (VRTX) Jumps: Stock Rises 6.6% - Tale of the Tape
9/22/2014 8:51:00 AM - Zacks.com

VIVUS and Auxilium Announce Stendra Label Expansion - Analyst Blog
9/19/2014 6:25:00 PM - Zacks.com

Bristol-Myers' (BMY) Yervoy Label Expanded in Canada - Analyst Blog
9/19/2014 5:40:00 PM - Zacks.com

Spectrum Pharmaceuticals Out-Licenses Products in China - Analyst Blog
9/19/2014 5:15:00 PM - Zacks.com

Bayer to Shed MaterialScience Business, Shares Rise - Analyst Blog
9/19/2014 5:10:00 PM - Zacks.com

Eli Lilly's Trulicity Approved by FDA for Type II Diabetes - Analyst Blog
9/19/2014 4:50:00 PM - Zacks.com

Is Merck KGaA on Track with its "Fit for 2018" Program? - Analyst Blog
9/19/2014 2:50:00 PM - Zacks.com

Dividend Aristocrats: Time to Buy AbbVie Inc Stock?
9/19/2014 12:32:06 PM - Motley Fool

Incyte: Increasing Sales, Deep Pipeline, Multiple Catalysts, With A Side Of M&A Chatter
9/19/2014 11:58:00 AM - Seeking Alpha

5 Things Gilead Sciences, Inc. Management Wants You to Know
9/19/2014 11:30:08 AM - Motley Fool

VIVUS Inc. (VVUS) Rises: Stock Adds 12.4% in Session - Tale of the Tape
9/19/2014 9:32:00 AM - Zacks.com

Gilead Emerging Market Agreement: Huge Win For Patients, Non-Event For Investors.
9/19/2014 9:26:00 AM - Seeking Alpha

Sector Update: Health-Care Shares Lower in Pre-Market Trade
9/19/2014 8:11:05 AM - MT Newswires

Sector Update: Health Care
9/19/2014 8:10:39 AM - MT Newswires

European Commission Grants Marketing Authorization To Gilead's Zydelig
9/19/2014 7:00:00 AM - RTT News

Sanofi & MyoKardia Ink Deal to Develop Cardiomyopathies - Analyst Blog
9/18/2014 5:35:00 PM - Zacks.com

Bayer/Orion Progress with Prostate Cancer Drug ODM-201 - Analyst Blog
9/18/2014 5:15:00 PM - Zacks.com